B4 RNA – B4 RNA | Detecting cancer before

ReJOIN-seq presented at Harvard Medical School

On Tuesday 28th April 2026, Juan Pablo Tosar, Founder and CSO of B4-RNA, presented ReJOIN-seq at a seminar titled “Beyond vesicles: update and sensing of inflammatory extracellular RNAs“. The talk was delivered as part of the seminar series hosted by the Initiative for RNA Medicine. This presentation marks a significant milestone for B4-RNA, as it […]

B4-RNA and Resolve Therapeutics Will Collaborate to Analyze Cell-Free RNA in Autoimmunity Using Proprietary Sequencing Technology

News / B4 RNA

Montevideo, Uruguay – April 7, 2026. – B4-RNA, a biotechnology company using its next-generation RNA sequencing technology platform to aid drug development, today announced a collaboration with Resolve Therapeutics. The collaboration will identify inflammatory RNA molecules circulating in the bloodstream of patients with autoimmune diseases that could become potential drug targets. Cell-free RNA (cfRNA) molecules

B4-RNA and Resolve Therapeutics Will Collaborate to Analyze Cell-Free RNA in Autoimmunity Using Proprietary Sequencing Technology Read More »